Powered, THC-Free Roll-On Formula with Broad-Spectrum Hemp Oil, Menthol, Camphor & Botanicals Emerges as a Leading Natural ...

Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time ...

Lobular breast cancer is more common than ovarian or skin cancer but there is little awareness around it, despite it being ...

Jill Feldman, cofounder and president, EGFR Resisters, shares the importance of being proactive in managing dermatologic toxicities in epidermal growth factor receptor (EGFR)–positive lung cancer.

This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor ...

University of Colorado Anschutz Medical Campus discusses what addiction is, including what may cause it and how empathy is a ...

A study has revealed why some patients don’t respond to immune checkpoint blockade (ICB) therapy for solid cancer tumours and ...

Epidemiologist Christine Ambrosone spoke about her work at the annual lecture named for the UB faculty member who helped ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

DermDox, a leading provider of the highest quality medical, surgical and aesthetic services has acquired the Dermatology Centers of NEPA. The acquisition includes two Pennsylvania locations in ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumours and identifies a new ...

Biotech firm Kymera Therapeutics announced strong results Monday, in the first human tests of a pill for autoimmune ailments like dermatitis and asthma. Its drug seems about a year ahead of other ...